RG
Rathbones Group’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $242M | Sell |
2,250,448
-88,943
| -4% | -$9.55M | 1.04% | 24 |
|
2025
Q1 | $236M | Sell |
2,339,391
-56,187
| -2% | -$5.67M | 1.14% | 21 |
|
2024
Q4 | $214M | Sell |
2,395,578
-9,880
| -0.4% | -$882K | 1.04% | 24 |
|
2024
Q3 | $202M | Sell |
2,405,458
-1,728
| -0.1% | -$145K | 1.02% | 23 |
|
2024
Q2 | $185M | Buy |
2,407,186
+53,770
| +2% | +$4.14M | 1.01% | 23 |
|
2024
Q1 | $161M | Buy |
2,353,416
+7,948
| +0.3% | +$544K | 0.93% | 26 |
|
2023
Q4 | $136M | Buy |
2,345,468
+82,646
| +4% | +$4.78M | 0.87% | 29 |
|
2023
Q3 | $119M | Buy |
2,262,822
+260,964
| +13% | +$13.8M | 0.87% | 30 |
|
2023
Q2 | $108M | Buy |
2,001,858
+556,884
| +39% | +$30.1M | 1.01% | 26 |
|
2023
Q1 | $72.3M | Sell |
1,444,974
-3,022
| -0.2% | -$151K | 0.74% | 42 |
|
2022
Q4 | $67M | Sell |
1,447,996
-2,779
| -0.2% | -$129K | 0.75% | 38 |
|
2022
Q3 | $56.2M | Buy |
+1,450,775
| New | +$56.2M | 0.69% | 40 |
|
2021
Q4 | – | Sell |
-6,245
| Closed | -$271K | – | 426 |
|
2021
Q3 | $271K | Buy |
+6,245
| New | +$271K | ﹤0.01% | 365 |
|
2021
Q1 | – | Sell |
-23,745
| Closed | -$854K | – | 407 |
|
2020
Q4 | $854K | Sell |
23,745
-169,940
| -88% | -$6.11M | 0.01% | 242 |
|
2020
Q3 | $7.4M | Sell |
193,685
-5,000
| -3% | -$191K | 0.13% | 104 |
|
2020
Q2 | $6.98M | Buy |
198,685
+25,205
| +15% | +$885K | 0.14% | 100 |
|
2020
Q1 | $5.66M | Sell |
173,480
-750,520
| -81% | -$24.5M | 0.16% | 95 |
|
2019
Q4 | $41.8M | Buy |
924,000
+109,979
| +14% | +$4.97M | 1.1% | 30 |
|
2019
Q3 | $33.1M | Buy |
814,021
+22,650
| +3% | +$922K | 0.94% | 40 |
|
2019
Q2 | $34M | Buy |
791,371
+658,328
| +495% | +$28.3M | 1.06% | 32 |
|
2019
Q1 | $5.11M | Buy |
133,043
+3,151
| +2% | +$121K | 0.17% | 98 |
|
2018
Q4 | $4.59M | Buy |
129,892
+51,821
| +66% | +$1.83M | 0.18% | 97 |
|
2018
Q3 | $3.01M | Buy |
+78,071
| New | +$3.01M | 0.1% | 111 |
|